Carregant...
SUN-173 Nivolumab-Induced Fulminant Autoimmune Diabetes Presenting as Diabetic Ketoacidosis in a Patient with Melanoma
Background: Anti PD-1 antibody immunotherapies like nivolumab and pembrolizumab are newer agents used in the treatment of melanoma and multiple other types of advanced cancers. Immune-mediated endocrinopathies triggered by these drugs are increasingly reported in literature and encountered by endocr...
Guardat en:
| Publicat a: | J Endocr Soc |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Endocrine Society
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553338/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-173 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|